Pulmonx Corporation
FAIR PRICE VALUATION
Our blended valuation model could not produce a fair price for Pulmonx Corporation right now. This usually happens when financial data is incomplete, the company recently went public, or it operates in a sector where standard valuation methods don't apply (e.g. early-stage biotech, REITs, or specialty financials). We re-run the model daily — check back soon.
MARKET PRICE
$1.45
FAIR PRICE
Pending
P/E Ratio
N/A
Div. Yield
N/A
ROE
-84.3%
Average
Market Cap
$61M
Small-cap
NOW AVAILABLE
Track LUNG in the Fair Price Index app
Add LUNG to your watchlist and we'll notify you the moment a fair price becomes available.
METHODOLOGY
How we calculate fair price
Our fair price is derived from a blended model that combines DCF analysis (50%), relative valuation against sector peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). For LUNG the model could not produce a result this run — typically due to incomplete financial data or a sector where standard valuation methods don't apply. Learn more about how fair value works.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting LUNG's risk profile.
RELATIVE · 30%
Comparing LUNG's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for LUNG, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate LUNG's fair value with your own inputs.
LUNG DCF Calculator
Pre-filled with LUNG's real free cash flow and share count — set your own growth and discount rate to calculate intrinsic value.
Graham Number
Enter LUNG's EPS and book value to see the maximum price Benjamin Graham would pay for this stock.
P/E Ratio Calculator
Check how much investors pay per dollar of LUNG's earnings and compare it against sector benchmarks.
EV/EBITDA Calculator
Compare LUNG against peers on a debt-adjusted basis using enterprise value and EBITDA.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for LUNG.
Explore on BuliosFAQ
Why is there no fair price for LUNG?+
Our blended valuation model could not produce a fair price for Pulmonx Corporation at this time. This usually happens when financial data is incomplete, the company recently went public, or it operates in a sector where standard valuation methods (DCF, P/E multiples, EV/EBITDA) don't apply well — for example early-stage biotech, REITs, or specialty financials. We re-run the model daily, so check back soon.
What is LUNG's current market price?+
Pulmonx Corporation (LUNG) currently trades at $1.45. Market price is provided by our data partner and updated daily.
Will LUNG get a fair price calculation later?+
Yes — we re-run the valuation model daily. As soon as the underlying financial data is sufficient and the model converges, LUNG's fair price will appear here automatically. You can also add LUNG to your watchlist in the Fair Price Index app and we'll notify you when a fair price becomes available.
What metrics are available for LUNG?+
For LUNG we currently have ROE of -84.3%. Sector classification: Healthcare.
How does Fair Price Index calculate fair value?+
Our blended model combines three approaches: discounted cash flow analysis (50% weight), relative valuation against sector peers using P/E and EV/EBITDA multiples (30% weight), and aggregated Wall Street analyst consensus (20% weight). When any of these inputs is missing or unreliable, the model abstains rather than producing a misleading number.
Can I estimate LUNG's fair value myself?+
Yes. You can use our DCF Calculator and Graham Number Calculator (linked above) to plug in your own assumptions and produce an independent estimate. These calculators are free and don't require a fair price from our model to work.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.